It's going over $15 really soon!

Today, Orphazyme $Orphazyme (ORPH.US)$ released a major shareholder statement. In this statement, the company announced that Goldman Sachs (NYSE:GS) had briefly taken a stake of more than 5% in ORPH stock. According to regulatory requirements, this stake had to be disclosed to shareholders.

Now, Goldman Sachs happens to have some of the world’s smartest analysts and investors working at its trading desk. Such a move appears to indicate to the market that the smart money knows something retail investors don’t. Accordingly, it appears today’s buying pressure is an indication investors may want to trade this speculative name. After all, if the selloff was overdone, some nice upside could be on the table.

Don't say bo jio ah~

$AMC Entertainment (AMC.US)$
$GameStop (GME.US)$
$ContextLogic (WISH.US)$
$Coinbase (COIN.US)$
$CytRx Corp (CYTR.US)$